Treatment patterns and survival differ between early-onset and late-onset colorectal cancer patients: the patient outcomes to advance learning network
| Autor: | Pamala A. Pawloski, Nirupa R. Ghai, Andrew T. Sterrett, Douglas A. Corley, Carmit K. McMullen, Heather Spencer Feigelson, Jessica Chubak, J. David Powers, Andrea N. Burnett-Hartman |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Oncology
Adult Male Cancer Research medicine.medical_specialty Adolescent Colorectal cancer medicine.medical_treatment Late onset Adenocarcinoma Systemic therapy 03 medical and health sciences Young Adult 0302 clinical medicine Internal medicine Epidemiology medicine Humans 030212 general & internal medicine Registries Age of Onset Proportional Hazards Models Chemotherapy Hematology business.industry Public health Immunotherapy Middle Aged medicine.disease 030220 oncology & carcinogenesis Female business Colorectal Neoplasms |
| Zdroj: | Cancer causescontrol : CCC. 30(7) |
| ISSN: | 1573-7225 |
| Popis: | Our objective was to describe differences in treatment patterns and survival between early-onset ( 50 years old) and late-onset colorectal cancer (CRC) patients in community-based health systems.We used tumor registry and electronic health record data to identify and characterize patients diagnosed with adenocarcinoma of the colon or rectum from 2010 to 2014 at six US health systems in the patient outcomes to advance learning (PORTAL) network. We used logistic regression to estimate adjusted odds ratios (ORs) and 95% confidence intervals (CIs) comparing the distribution of tumor characteristics and treatment patterns in early-onset versus late-onset CRC. Cox regression models were used to estimate adjusted hazard ratios (HRs) and CIs comparing survival between early- and late-onset CRC patients.There were 1,424 early-onset and 10,810 late-onset CRC cases in our analyses. Compared to late-onset CRC, early-onset CRC was significantly associated with advanced-stage disease, high-grade histology, signet ring histology, and rectal or left colon location. After adjusting for differences in tumor and patient characteristics, early-onset patients were more likely than late-onset patients to have 12 lymph nodes examined (OR 1.60, CI 1.37-1.87), to receive systemic therapy (chemotherapy or immunotherapy) within 6 months of diagnosis (OR 2.84, CI 2.40-3.37), and to have a reduced risk of CRC-specific death (HR 0.66, CI 0.56-0.79).Early-onset CRC is associated with aggressive tumor characteristics, distal location, and systemic therapy use. Despite some adverse risk factors, these patients tend to have better survival than older onset patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink